Back to Stocks
Stock detail
Eli Lilly and Company
LLYSTOCKS | US | NYSE | Healthcare | Drug Manufacturers - General
Profile snapshotUSD 1,222.6Market cap USD 1.2T
No local candle data found.
Recent detected patterns / setups
Latest 10 Market Radar results for this symbol.
PatternTFDetectedQuality
BullishOrder Block Setup15M28 Jul 26, 15:4578
BullishOliver Kell Momentum Setup15M28 Jul 26, 15:4583
BearishOrder Block Setup4H28 Jul 26, 13:3066
BullishFVG Reaction Setup4H + 15M28 Jul 26, 15:4569
BullishOliver Kell Momentum Setup4H28 Jul 26, 13:3080
BullishMA 8/21 Crossover4H28 Jul 26, 13:3083
BullishMinervini Trend Template4H28 Jul 26, 13:3084
BullishFVG Reaction Setup1D + 15M28 Jul 26, 15:4568
BearishGartley15M28 Jul 26, 15:4564
BullishRange Continuation4H28 Jul 26, 13:3093
Annual
Annual fundamentals
2025 vs previous annual period
Metric202020212022202320242025
Total revenueUSD 24.5B+9.9%USD 28.3B+15.4%USD 28.5B+0.8%USD 34.1B+19.6%USD 45B+32.0%USD 65.2B+44.7%
Net incomeUSD 6.2B-25.5%USD 5.6B-9.9%USD 6.2B+11.9%USD 5.2B-16.1%USD 10.6B+102.1%USD 20.6B+94.9%
Net profit margin25.2%-32.3%19.7%-21.9%21.9%+11.0%15.4%-29.8%23.5%+53.1%31.7%+34.7%
EPS6.47-25.5%5.85-9.6%6.57+12.3%5.83-11.3%11.76+101.7%23+95.6%
Quarterly
Quarterly fundamentals
Q1 2026 vs same quarter previous year
MetricQ4 2024Q1 2025Q2 2025Q3 2025Q4 2025Q1 2026
Total revenueUSD 13.5B+44.7%USD 12.7B+45.2%USD 15.6B+37.6%USD 17.6B+53.9%USD 19.3B+42.6%USD 19.8B+55.5%
Net incomeUSD 4.4B+101.4%USD 2.8B+23.0%USD 5.7B+90.8%USD 5.6B+475.3%USD 6.6B+50.5%USD 7.4B+168.0%
Net profit margin32.6%+39.2%21.7%-15.3%36.4%+38.6%31.7%+273.9%34.4%+5.6%37.4%+72.3%
EPS4.91+102.1%3.07+23.3%6.3+91.5%6.22+475.9%7.41+50.9%8.27+169.4%
Ownership
Institutional ownership summary
2026 Q2, quarter ended 2026-06-30
PeriodOwnershipInstitutions13F sharesTotal investedPositionsPut/call
2026 Q22026-06-30